RNU6-1271P

Across TCGA pan-cancer cohorts, RNU6-1271P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-1271P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-1271P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1271P expression acts as an unfavorable survival marker.

KIRC, STAD, and ACC are the cancer types where RNU6-1271P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.148	0.619	.014	54	view →
STAD	DFS	Tertile	All	0.226	0.719	<.001	36	view →
ACC	DFS	Tertile	All	0.115	0.595	.027	36	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNU6-1271P–KIRC (DFS)

Open the KIRC breakdown →